Literature DB >> 28980289

Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry.

Rosa Agra Bermejo1, Eva Gonzalez Babarro, J Nicolás López Canoa, Alfonso Varela Román, Inés Gómez Otero, Marcos Oro Ayude, Pablo Parada Vazquez, Isabel Gómez Rodríguez, Oscar Díaz Castro, Jose Ramón González Juanatey.   

Abstract

BACKGROUND: The magnitude and the prognostic impact of recovering left ventricular ejection fraction (LVEF) in patients with heart failure (HF) and systolic dysfunction is unclear. The aim of this study was to evaluate the clinical characteristics and prognosis of patients with HFrecEF in an HF population.
METHODS: 449 consecutive patients were selected with the diagnosis of HF and an evaluation of LVEF in the 6 months prior to selection who were referred to two HF units. Patients with systolic dysfunction were only considered if a second echocardiogram was performed during the follow-up.
RESULTS: At the time of diagnosis, 207 patients had LVEF > 40% (HFpEF) and 242 had LVEF ≤ 40% (HFrEF). After 1 year, the LVEF was re-evaluated in all 242 patients with a LVEF ≤ 40%: in 126 (52%), the second LVEF was > 40% (HFrecEF), and the remaining 116 (48%) had LVEF ≤ 40% (HFrEF). After 1800 ± 900 days of follow-up patients with recovered LVEF had a significantly lower mortality rate (HFpEF vs. HFrecEF: hazard ratio [HR] = 2.286, 95% confidence interval [95% CI] 1.264-4.145, p = 0.019; HFrEF vs. HFrecEF: HR = 2.222, 95% CI 1.189-4.186, p < 0.001) and hospitalization rate (HFpEF vs. HFrecEF: HR = 1.411, 95% CI 1.046-1.903, p = 0.024; HFrEF vs. HFrecEF: HR = 1.388, 95% CI 1.002-1.924, p = 0.049). The following are predictors of LVEF recovery: younger age, lower functional class, treatment with renin-angiotensin-aldosterone system inhibitors and beta-blockers, absence of defibrillator use, and non-ischemic etiology.
CONCLUSIONS: Patients with HF and reduced LVEF who were re-evaluated after 1 year, had significant improvement in their LVEF and had a more favourable prognosis than HF with preserved and reduced ejection fraction.

Entities:  

Keywords:  heart failure; left ventricular ejection fraction; recovered

Mesh:

Year:  2017        PMID: 28980289     DOI: 10.5603/CJ.a2017.0103

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  7 in total

Review 1.  Risk of heart failure progression in patients with reduced ejection fraction: mechanisms and therapeutic options.

Authors:  Edoardo Gronda; Emilio Vanoli; Stefania Sacchi; Guido Grassi; Giuseppe Ambrosio; Claudio Napoli
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

2.  Ischemic and non-ischemic patterns of late gadolinium enhancement in heart failure with reduced ejection fraction.

Authors:  Patrycja S Matusik; Amira Bryll; Paweł T Matusik; Tadeusz J Popiela
Journal:  Cardiol J       Date:  2020-02-10       Impact factor: 2.737

3.  Prognosis and diastolic dysfunction predictors in patients with heart failure and recovered ejection fraction.

Authors:  Takuma Takada; Katsuhisa Matsuura; Yuichiro Minami; Takuro Abe; Ayano Yoshida; Makoto Kishihara; Shonosuke Watanabe; Shota Shirotani; Kentaro Jujo; Nobuhisa Hagiwara
Journal:  Sci Rep       Date:  2022-05-24       Impact factor: 4.996

Review 4.  Female Gender Is Associated with an Increased Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure with Reduced Ejection Fraction.

Authors:  Jakrin Kewcharoen; Angkawipa Trongtorsak; Sittinun Thangjui; Chanavuth Kanitsoraphan; Narut Prasitlumkum
Journal:  Med Sci (Basel)       Date:  2022-04-02

5.  The relation between cardiac 123I-mIBG scintigraphy and functional response 1 year after CRT implantation.

Authors:  D O Verschure; E Poel; G De Vincentis; V Frantellizzi; K Nakajima; O Gheysens; J R de Groot; H J Verberne
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2021-01-01       Impact factor: 6.875

6.  Prevalence and Prognosis of HFimpEF Developed From Patients With Heart Failure With Reduced Ejection Fraction: Systematic Review and Meta-Analysis.

Authors:  Yibo He; Yihang Ling; Wei Guo; Qiang Li; Sijia Yu; Haozhang Huang; Rongting Zhang; Zhiwen Gong; Jiaxuan Liu; Liyi Mo; Shixin Yi; Disheng Lai; Younan Yao; Jin Liu; Jiyan Chen; Yong Liu; Shiqun Chen
Journal:  Front Cardiovasc Med       Date:  2021-11-25

Review 7.  Heart failure with recovered ejection fraction and the utility of defibrillator therapy: a review.

Authors:  Jasneet K Devgun; Samuel Kennedy; Jeremy Slivnick; Zachary Garrett; Katherine Dodd; Mohamed H Derbala; Cristina Ortiz; Sakima A Smith
Journal:  ESC Heart Fail       Date:  2021-12-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.